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Introduction: Opioids contributed to over 300,000 deaths in the United States in the past 10 years. 
Most research on drug use occurs in clinics or hospitals; few studies have evaluated the impact 
of opioid use on emergency medical services (EMS) or the EMS response to opioid use disorder 
(OUD). This study describes the perceived burden of disease, data collection, and interventions in 
California local EMS agencies (LEMSA).
Methods: We surveyed medical directors of all 33 California LEMSAs with 25 multiple-choice and 
free-answer questions. Results were collected in RedCap and downloaded into Excel (Microsoft 
Corporation, Redmond WA). This study was exempt from review by the Alameda Health System - 
Highland Hospital Institutional Review Board.
Results: Of the 33 California LEMSAs, 100% responded, all indicating that OUD significantly 
affects their patients. Most (91%) had specific protocols directing care of those patients and repeat 
naloxone dosing. After naloxone administration, none permitted release to law enforcement custody, 
6% permitted patient refusal of care, and 45% directed base hospital contact for refusal of care. Few 
protocols directed screening or treatment of OUD or withdrawal symptoms. Regular data collection 
occurred in 76% of LEMSAs, with only 48% linking EMS data with hospital or coroner outcomes. In 
only 30% did the medical director oversee regular quality improvement meetings. Of respondents, 
64% were aware of public health agency-based outreach programs and 42% were aware of 
emergency department BRIDGE programs (Medication Assisted Treatment and immediate referral). 
Only 9% oversaw naloxone kit distribution (all under the medical director), and 6% had EMS-based 
outreach programs. In almost all (94%), law enforcement officers carried naloxone and administered 
it anywhere from a few times a year to greater than 200 in one LEMSA. 
Conclusion: This study represents an important description of EMS medical directors’ approaches 
to the impact of OUD as well as trends in protocols and interventions to treat and prevent overdoses. 
Through this study, we can better understand the variable response to patients with OUD across 
California. [West J Emerg Med. 2020;21(3)671-676.]
INTRODUCTION
Drug overdoses have led to more than half a million deaths 
in the United States in the last 10 years, two-thirds of which 
were opioid-related.1 Opioid-related deaths increased fivefold 
from 1999 to 2016,2 and became the leading cause of accidental 
death in the US in 2015.3 While heroin and other illicit opioids 
contributed to the epidemic, prescription opioids constituted 
the bulk of the drugs leading to overdose.4-6 Although poorly 
characterized, the impact to the emergency medical services 
(EMS) system is significant. Naloxone administration was 
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Population Health Research Capsule
What do we already know about this issue?
The Centers for Disease Control declared 
opioid overdoses to be a national health crisis. 
What was the research question?
We surveyed the medical directors of all 33 
California Local Emergency Medical Services 
(EMS) Agencies to define perception and 
response to opioid use disorder.
What was the major finding of the study?
While all Local EMS Agencies perceived the 
burden of opioid use disorder to be significant, 
few had built EMS-based outreach programs in 
response.
How does this improve population health?
We provide EMS agencies with information 
about variation in perception and response to 
opioid use disorder.
documented in nearly half a million EMS runs nationally from 
2014 to 2016, as presented by the National EMS Information 
System (NEMSIS).7
In response, institutions and governments rolled out 
programs to curb the epidemic at every level of healthcare 
delivery. Broadly, the Centers for Disease Control and Prevention 
(CDC) recommended a five-pronged response: perform 
surveillance and research; empower consumers to make safe 
choices; build state, local, and tribal capacity; partner with public 
safety; and support providers, health systems, and payers.8 
Specifically, the CDC recommended that states emphasize 
surveillance, policies, and funding to reduce prescription size and 
number, increase access to medication assisted therapy (MAT), 
and expand first responder access to naloxone.8 As a result, local, 
regional, and national governments implemented laws to reduce 
supply, monitor use, and enhance response to overdoses.9
Across the country, legal immunity has been granted to 
clinicians prescribing naloxone to third parties and bystanders 
aiding overdose patients in possession of illicit drugs.10,11 
Naloxone is now widely available at pharmacies through 
physician standing orders.10,11 Community groups designed kits 
with naloxone and educational programs to teach laypersons how 
to correctly identify and treat opioid overdose.12-14 Many EMS 
medical directors expanded the scope of practice for naloxone 
administration to include law enforcement personnel and other 
non-paramedic first responders.15-18
Most research and data collection has focused on patients 
who use opioids in hospital and clinic settings. Little research 
explores the burden of disease and scope of response in the 
prehospital setting. In the state of California, oversight of EMS 
and coordination of care are accomplished through medical 
directors in 33 local emergency medical system agencies 
(LEMSA). According to the US Census Bureau, LEMSAs 
provide care to a population greater than 39 million that is spread 
across an area of nearly 156 thousand square miles, diverse in 
urbanicity and demographics. Each LEMSA regulates prehospital 
care with independent protocols that can vary widely from one 
region to the next. In this paper, we surveyed medical directors 
in all 33 LEMSAs within California to describe local approaches 
to opioid use disorder (OUD), access to data on patients who 
overdose from opioids, and community harm-reduction programs 
to prevent opioid overdoses. 
METHODS
In March 2019, we sent a survey via electronic mail to the 
medical directors of the 33 LEMSAs in California. One survey 
was to be completed for each LEMSA by either the medical 
director for that LEMSA or a representative. After six weeks, we 
sent reminder emails to medical directors who had not completed 
the survey. Incomplete or conflicting data was resolved with a 
follow-up phone call or electronic mail to the medical director.
We developed the survey by committee consensus. The 
survey highlighted three main outcomes: local perception of 
burden of OUD and protocols to respond to opioid overdoses; 
access to data on patients who overdosed from opioids; and 
community harm-reduction programs to prevent further opioid 
overdoses. Within those three areas, we asked 25 questions, 
in a combination of multiple-choice and free-answer formats 
(Appendix A). Results were collected in RedCap and downloaded 
into Excel (Microsoft Corporation, Redmond WA) for data 
analysis. We present a descriptive analysis of the results.
RESULTS
Local Perception And Protocols
All 33 LEMSAs responded to the survey and all indicated 
that OUD significantly affects patients in their areas. Most 
(91%) had specific protocols directing care of those patients 
as well as directing repeat dosing of naloxone. When they 
existed, those protocols specified a range from one re-dose to 
unlimited, titrating to effect. Few LEMSAs had policies for 
patient refusal of care after naloxone administration, but nearly 
half had policies directing base hospital physician contact when 
a patient refused transport after naloxone administration. No 
LEMSA had a protocol to release a patient to law enforcement 
custody after naloxone administration, screen patients for 
withdrawal symptoms, or distribute naloxone to patients in the 
field. However, after base hospital physician contact was made, 
some LEMSAs (36%) permitted patients to be released to law 
enforcement custody after naloxone administration, and a few 
LEMSAs (9%) permitted treatment of patients with opioid 
withdrawal syndrome (Table 1 and Figure 1).
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Table 1. Percentage (number) of local emergency medical services agencies (LEMSA) with protocols to understand and regulate a 
response to patients with opioid use disorder.
Survey question Affirmative response
Does your LEMSA have a specific protocol directing care for patients with suspected opioid overdose? 91% (30)
Does your LEMSA have a protocol for repeated dosing of naloxone? 91% (30)
Does your LEMSA have a specific protocol for patient refusal and release from care following administration 
of naloxone or suspected overdose?
6% (2)
Does your refusal policy require base hospital physician contact for refusals following naloxone administration? 45% (15)
Does your LEMSA have a specific protocol for treating a patient with naloxone and releasing the patient to 
law enforcement custody?
0% (0)
Does your LEMSA have a specific protocol for screening patients for opioid use disorder? 3% (1)
Does your LEMSA have a specific protocol for distributing a naloxone kit to patients? 0% (0)
Does your LEMSA have a specific protocol for screening patients for opioid withdrawal syndrome? 0% (0)
Does your LEMSA have a specific protocol for treating patients with opioid withdrawal syndrome? 3% (1)
Figure 1. Percentage of emergency medical services agencies (LEMSA) that did or did not have protocols to understand and regulate 
a response to patients with opioid use disorder.
Access to Data on Patients Who Overdose from Opioids
Of all LEMSAs, 76% collected data on opioid overdoses, 
but only 48% linked data with hospital and coroner outcomes. 
In only 30% did the medical director regularly oversee quality 
improvement (QI) meetings to review the data. The QI meetings 
varied from review of law enforcement naloxone administration 
to review of cases in which naloxone was administered, to 
review of presumed opioid overdoses by an epidemiologist. Of 
those with a regular QI process, 38% examined the geographic 
distribution of naloxone administration within their LEMSA.
Community Programs to Prevent Opioid Overdoses
More than half of respondents were aware of public 
health agency-based outreach programs for harm reduction or 
emergency department (ED) BRIDGE programs – ED-based 
buprenorphine prescribing with rapid access to outpatient 
follow-up. When they existed, those programs varied widely 
and included law enforcement distribution of naloxone, public 
health outreach, multidisciplinary committees, ED referral 
to outpatient BRIDGE programs, and sheriff department 
distribution of naloxone to recently released inmates. In one 
LEMSA, the respondent replied that there was no such program, 
and in the rest (33%), the respondents indicated uncertainty 
as to whether such a program existed. Few LEMSAs oversaw 
naloxone kit distribution or had EMS-based outreach programs. 
In almost all (94%), law enforcement officers carried naloxone. 
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Most started within the past two years, and one started four 
years ago. Use of law enforcement naloxone varied from a few 
uses a year to greater than 200 in one LEMSA (Table 2 and 
Figure 2).
DISCUSSION
This study highlighted the variable EMS response to OUD 
across California. Prehospital administration of naloxone for 
patients with suspected opioid overdose has proven safe and 
effective for 30 years,19 and is now standard practice in the 
US.20 Our results suggest that California medical directors 
are uniformly aware of the impact of the opioid epidemic. 
Accordingly, LEMSAs widely adopted protocols for naloxone 
administration, re-dosing, and use by law enforcement, 
consistent with the national standard of practice.
Few LEMSAs implemented specific protocols allowing 
patients to refuse transport after naloxone. While emerging data 
from the prehospital setting indicates patients who sign out 
against medical advice following naloxone reversal have low 
Survey question  Affirmative response
Are there any public health agency-based outreach or harm reduction programs for patients with opioid use 
disorder within the county(ies) served by your LEMSA?
64% (21)
Does your LEMSA oversee a naloxone kit distribution program? 9% (3)
Do law enforcement officers carry naloxone within the counties served by your LEMSA? 94% (31)
Are you aware of any emergency department BRIDGE programs within the counties served by your LEMSA? 
(Patients treated and discharged with buprenorphine-naloxone and referral)
42% (14)
Within your LEMSA, do you have any EMS-based outreach programs? (eg, paramedics distributing 
information to at-risk patients and family members, prehospital distribution of buprenorphine-naloxone, 
referrals by prehospital providers to treatment programs)
9% (3)
Table 2. Percentage (number) of emergency medical services agencies (LEMSA) with programs to prevent opioid overdoses.
mortality as a result of rebound toxicity,21-24 these studies were 
mostly limited to heroin and morphine overdose Little to no 
data exists on high-potency opioids (fentanyl and its analogs) or 
long-acting opioids. Current literature suggests an observation 
period of at least one hour following reversal of opioid overdose 
with naloxone in the ED.25,26 Given the rise in overdose deaths 
from high-potency opioids,27,28 some groups have recommended 
longer observation periods, up to six hours.29 
The question of how to safely and ethically care for 
these patients is a complex one. Medically, further studies are 
needed to continue to evaluate the safety of patient release 
after naloxone administration in the setting of increasing use of 
high-potency synthetic opioids. Ethically, we must balance the 
medical prerogative of autonomy with that of non-malfeasance. 
We must allow those patients to determine their own medical 
care, while simultaneously evaluating whether or not 
administration of naloxone and subsequent release is consistent 
with the medical principle “first, do no harm.” Furthermore, 
non-transport of patients after naloxone administration could 
Figure 2. Percentage of emergency medical services agencies (LEMSA) that did or did not have programs to prevent opioid overdoses.
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represent a lost opportunity to provide therapy and counseling 
in the ED.
Available data suggests that efforts aimed at increasing 
community access to naloxone decrease mortality from opioid 
overdose.30-34 In their guidelines on community management 
of opioid overdose, the World Health Organization issued a 
strong recommendation to distribute naloxone to individuals 
likely to witness an opioid overdose.35 Across the country, 
naloxone distribution programs are expanding in number and 
scope.36 EMS providers frequently encounter individuals at 
high risk for repeat overdose and individuals who are likely to 
witness an overdose.20,37 Despite this, only 9% of California 
LEMSAs oversee a naloxone distribution program. Further, 
only 64% were aware of public health outreach or harm 
reduction programs within their jurisdictions, and less than 
half of the LEMSA medical directors surveyed were aware of 
BRIDGE programs to connect patients with MAT centers. This 
demonstrates the disconnect between awareness and action 
and shows a potential growth area for LEMSAs to more fully 
address the public health burden. The development of EMS 
“leave behind” naloxone programs is an emerging strategy38-40 
for stakeholders seeking to exploit this previously missed 
opportunity to intervene at the site of an overdose.
LIMITATIONS
This study is limited in scope to examining EMS system 
protocols in only one state, California. Therefore, its findings may 
not be generalizable to trends or experiences in addressing opioid-
related issues in other geographic settings. Additionally, as a survey 
based-study, the findings are limited to exploring approaches 
of EMS medical directors and protocols rather than examining 
outcome data for opioid-related EMS calls between LEMSAs. 
This study does not attempt to compare prehospital practices or 
outcomes with those described in hospital and clinic settings. 
CONCLUSION
Significant variation exists throughout the state in 
prehospital response to patients with opioid use disorder. 
The responses indicate an awareness of some harm-reduction 
principles for acute overdose (such as law enforcement 
naloxone), but little initiation of EMS-led programs such as 
naloxone distribution to the community sites or linkage with 
MAT programs. We hope that this study will prove useful to 
medical directors in California and throughout the US as they 
continue their efforts to respond appropriately and effectively 
to opioid use disorder.
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